How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenarioReview Published on 2020-11-192022-10-27 Journal: BMC Gastroenterology [Category] COVID-19, [키워드] applied celiac disease clinical picture conscious coronavirus COVID-19 diffusion disease flu-like symptom Gluten-free diet interstitial pneumonia limit Local management manuscript outbreak outcome pandemic Patient precautions risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection Support therapy Treatment Vaccine virus [DOI] 10.1186/s12876-020-01524-4 PMC 바로가기 [Article Type] Review
Psychological Impact of Health Risk Communication and Social Media on College Students During the COVID-19 Pandemic: Cross-Sectional StudyOriginal Paper Published on 2020-11-182022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, SARS, [키워드] 95% CI addition affected Anxiety association checklist China Chinese college communication COVID-19 demographics expected Health Health anxiety Health risk Impact independent risk factors information Intervention inventory investigated Logistic regression measure media objective Odds ratio outbreak pandemic Panic Perceived phobia platform Prevalence preventive measure Prognosis protective factor psychological health psychological symptom psychological symptoms reported Research Result risk risk factor risk of COVID-19 shown social contact social media social media platforms Spread student was collected was performed was used wearing face mask [DOI] 10.2196/20656 PMC 바로가기 [Article Type] Original Paper
Obesity population at risk of COVID-19 complicationsCOVID-19 합병증의 위험이 있는 비만 인구Review Published on 2020-11-062022-09-12 Journal: Global health, epidemiology and genomics [Category] MERS, 진단, [키워드] administration cause chronic inflammation co-morbidity Complication complications coronavirus COVID-19 COVID-19 infection COVID-19 vaccination deficiency ENhance Epidemic global health Healthcare system healthy Immunity invasive ventilation lung mental health obese obesity pandemic physical activity Population health Prevalence preventive measure promote Prophylactic Psychological public health quarantine recommendation required Result risk of COVID-19 Self-isolation social distancing susceptibility was performed with COVID-19 [DOI] 10.1017/gheg.2020.6 PMC 바로가기 [Article Type] Review
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platformArticles Published on 2020-11-052022-10-29 Journal: The Lancet Rheumatology [Category] COVID-19, [키워드] 95% CI absolute difference acute respiratory syndrome age Analysis association biologic clinical study coronavirus COVID-19 COVID-19 mortality COVID-19 outbreak Cox regression cumulative death deaths disease Effect Effectiveness England epithelial cell Estimated evaluate Evidence finding funding General population geographical region Hydroxychloroquine immunosuppressive drugs in vitro indicated information inhibit Interaction Medical Research Council Model Mortality National negative control Non-COVID-19 Older OpenSAFELY outcome Patient patients with COVID-19 platform population-based cohort prevention of COVID-19 primary care Prophylactic Randomised trial reduced Registered rheumatoid arthritis rheumatological risk of COVID-19 robust SARS-CoV-2 Sex shown systemic lupus erythematosus the disease Treatment use of hydroxychloroquine with COVID-19 [DOI] 10.1016/S2665-9913(20)30378-7 PMC 바로가기 [Article Type] Articles
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?COVID-19 너머: 항-CD20 요법으로 치료받은 MS/NMO-SD 환자에게 SARS-CoV2 항체가 발생합니까?Article Published on 2020-11-012022-08-31 Journal: Multiple sclerosis and related disorders [Category] SARS, 바이오마커, [키워드] agent anti-CD20 anti-CD20 therapy consequence coronavirus Coronavirus infection COVID-19 COVID-19 infection develop disorder immune response immunosuppressants Infection Multiple multiple sclerosis Neuromyelitis Optica New coronavirus Patient patients treated Precaution Prevent risk of COVID-19 SARS-CoV-2 SARS-CoV2 serology Spread treated [DOI] 10.1016/j.msard.2020.102482 PMC 바로가기 [Article Type] Article
Older adults’ strategies for obtaining medication refills in hypothetical scenarios in the face of COVID-19 riskCOVID-19 위험에 직면한 가상 시나리오에서 약물 재충전을 위한 노인의 전략Article Published on 2020-11-012022-09-11 Journal: Journal of the American Pharmacists Association : [Category] 치료제, [키워드] analyses Care Comorbidities Comorbidity coronavirus coronavirus disease COVID-19 demographic factor demographics determine except for experiment Factor Gender Health health condition hypothetical insulin less medication medications Medicine MOST multinomial logistic regression Older older adult Older adults pandemic participant Pharmacy preference preferences questionnaire reported restrict Restricting risk Risk factors risk of COVID-19 setting tramadol with COVID-19 women zolpidem zolpidem) [DOI] 10.1016/j.japh.2020.06.016 PMC 바로가기 [Article Type] Article
Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19코로나바이러스감염증-19(COVID-19) 전 몇 주 동안 최적의 수분 공급이 COVID-19로 인한 사망의 위험 요소라는 가설Article Published on 2020-11-012022-09-11 Journal: Medical Hypotheses [Category] 유전자 메커니즘, [키워드] ACE2 ACE2 receptors active transport airway airways aldosterone angiotensin angiotensin converting enzyme AQP5 aquaporin Attention balance body water capillary leakage chronic chronic disease Chronic hydration coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 mortality COVID-19 testing drinking water Drinking water intervention Effect endothelial enzyme epidemiological epithelial cells Evidence exaggerated immune response exposure to favor greater growth factor Hydration Hypertonicity hypothese hypotheses Hypovolemia increase Infection intake kinase likelihood limit lung lung epithelial cell Lung epithelial cells Male sex mechanism Mortality Older age pathway Pathways positive public health receptor recommendation reduce reduced risk factor Risk factors risk of COVID-19 risk reduction Saliva osmolality SGK1 Signaling TNF-alpha total body total body water Transport Treatment Tumor tumor necrosis tumor necrosis factor tumor necrosis factor-alpha Vascular vascular endothelial growth factor VEGF VEGF. Via water Water balance [DOI] 10.1016/j.mehy.2020.110237 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis낭포성 섬유증 환자의 벨기에 코호트에서 SARS-CoV-2 혈청 유병률Article Published on 2020-11-012022-09-11 Journal: Journal of cystic fibrosis : official journal of t [Category] MERS, SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody anti-SARS-CoV-2 IgM asymptomatic patient asymptomatic patients Belgium Clinical data Clinique cohort of patient collected concerning COVID-19 COVID-19 symptom COVID-19 symptoms Cystic cystic fibrosis detect Diagnosis difficulty fibrosis Government Hospitalized IgG IgG antibodies IgG antibody lockdown molecular one patient Patient positive respiratory respiratory symptom respiratory symptoms risk of COVID-19 SARS-CoV-2 SARS-CoV-2 seroprevalence Seroprevalence symptomatic patient virus with COVID-19 [DOI] 10.1016/j.jcf.2020.08.005 PMC 바로가기 [Article Type] Article
CD147 as a novel receptor in the pathogenesis of SARS-CoV-2: Is there any correlation with the risk of COVID-19 in dermatological diseases?SARS-CoV-2의 병인에서 새로운 수용체로서의 CD147: 피부병에서 COVID-19의 위험과 어떤 상관관계가 있습니까?Comment Published on 2020-11-012022-09-11 Journal: Dermatologic therapy [Category] SARS, 바이오마커, [키워드] CD147 correlation Pathogenesis receptor risk of COVID-19 [DOI] 10.1111/dth.14443 PMC 바로가기 [Article Type] Comment
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort StudyArticle Published on 2020-10-312022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 95% CI age Cohort Containment measure Corticosteroid COVID-19 cumulative detrimental died drugs effective enrolled General population Hospitalization Hospitalized IBD Immunosuppression impacted incidence incidence of COVID-19 Increased increased risk increased the risk Inflammatory bowel disease intensive care unit investigated lethality lockdown monoclonal antibody multicenter multivariable analysis outcome Patient pharmacological Pneumonia preventing infection reduced risk risk risk of COVID-19 SARS-COV-2 infection Treatment [DOI] 10.3390/jcm9113533 PMC 바로가기 [Article Type] Article